Induction of pneumococcal polysaccharide-specific mucosal immune responses by oral immunization

Vaccine

Volumn 14, Issue 5, 1996, Pages 392-398

  VanCott, John L ^a   Kobayashi, Toshiya ^a,b   Yamamoto, Masafumi ^a   Pillai, Subramonia ^c   McGhee, Jerry R ^a   Kiyono, Hiroshi ^a,d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

^c Lederle Praxis Biologicals   (United States)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

Mucosal immunity; Oral immunization; Polysaccharide specific responses

Indexed keywords

CHOLERA TOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; IMMUNOLOGICAL ADJUVANT; LIPOSOME; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0029881522     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00198-A     Document Type: Article

References (50)

1. Bruyn, G.A.W., Zegers, B.J.M. and van Furth, R. Mechanisms of host defense against infection with Streptococcus pneumoniae. Clin. Infect. Dis. 1992, 14, 251
2. Robbins, J.B., Austrian, R., Lee, C.-J. et al. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J. Infect Dis. 1983, 148, 1136
3. Musher, D.M. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin. Infect. Dis. 1992, 14, 801
4. Breiman, R.F., Butler, J.C., Tenover, F.C., Elliot, J.A. and Facklam, R.R. Emergence of drug-resistant pneumococcal infections in the United States. J. Am. Med. Assoc. 1994, 271, 1875
5. Welby, P.L., Keller, D.S., Cramien, J.L., Tebas, P. and Starch, G.A. Resistance to penicillin and non-beta-lactam antibiotics of Streptococcus pneumoniae at a children's hospital. Ped. Infect. Dis. J. 1994, 13, 281
6. McGhee, J.R., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M. and Kiyono, H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992, 10, 75
7. Gleeson, M., Cripps, A.W., Clancy, R.L., Husband, A.J., Hensley, M.J. and Leeder, S.R. Ontogeny of the secretory immune system in man. Aust. N.Z. J. Med. 1982, 12, 255
8. Burgio, G.R., Lanzavecchia, A., Plebani, A., Jayakar, S. and Ugazio, A.G. Ontogeny of secretory immunity: levels of secretory IgA and natural antibodies in saliva. Ped. Res. 1980, 14, 1111
9. Ogra, P.L. Mucosal immune response to poliovirus vaccines in childhood. Rev. Infect. Dis. 1984, 6 Suppl. 2, S361
10. Allansmith, M., McClellan, B.H., Butterworth, M. and Maloney, J.R. The development of immunoglobulin levels in man. J. Ped. 1968, 72, 276
11. Garg, M. and Subbarao, B. Immune responses of systemic and mucosal lymphoid organs to pnu-immune vaccine as a function of age and the efficacy of monophosphoryl lipid A as an adjuvant. Infect. Immun. 1992, 60, 2329
12. Szewczuk, M.R., Campbell, R.J. and Jung, L.K. Lack of age-associated immune dysfunction in mucosal-associated lymph nodes. J. Immunol. 1981, 126, 2200
13. Elson, C.O. and Ealding, W. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated antigen. J. Immunol. 1984, 133, 2892
14. Jackson, R.J., Fujihashi, K., Xu-Amano, J., Kiyono, H., Elson, C.O. and McGhee, J.R. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect. Immun. 1993, 61, 4272
15. Abraham, E. Intranasal immunization with bacterial polysaccharide containing liposomes enhances antigen-specific pulmonary secretory antibody response. Vaccine 1992, 10, 461
16. Abraham, E. and Shah, S. Intranasal immunization with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specific pulmonary secretory antibody response. J. Immunol. 1992, 149, 3719
17. Abraham, E. and Robinson, A. Oral immunization with bacterial polysaccharide and adjuvant enhances antigen-specific pulmonary secretory antibody response and resistance to pneumonia. Vaccine 1991, 9, 757
18. 197. In: Mucosal Immune Response to Pneumococcal Polysaccharides in the Rat. 1994, pp. 131-146
19. van den Dobbelsteen, G.P.J.M., Nieminen, T., Saarinen, L. et al. Different roles of alveolar macrophages in vivo in the defense against Streptococcus pneumoniae types 3 and 14. In: Mucosal Immune Response to Pneumococcal Polysaccharides in the Rat. 1994, pp. 77-91
20. deVos, T. and Dick, TA. A rapid method to determine the isotype and specificity of coproantibodies in mice infected with Trichinella or fed cholera toxin. J. Immunol. Meth. 1991, 141, 285
21. Gray, B. ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes. J. Immunol. Meth. 1979, 28, 187
22. + T cells that secrete IFN-γ and IL-5. J. Immunol. 1990, 145, 68
23. Czerkinsky, C.C., Nilsson, L.A., Nygren, H., Ouchterlony, O. and Tarkowski, A. A solid phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody secreting cells. J. Immunol. Meth. 1983, 65, 109
24. Claassen, E., Kors, N., Dijkstra, C.D. and Van Rooijen, N. Marginal zone of the spleen and the development and localization of specific antibody forming cells against thymus dependent and thymus-independent type 2 antigens. Immunology 1986, 57, 399
25. Kraal, G., ter Hart, H., Meelhuizen, C., Venneker, G. and Claassen, E. Marginal zone macrophages and their role in the immune response against T-independent type 2 antigens: modulations of the cells with specific antibodies. Eur. J. Immunol. 1989, 19, 675
26. van Dam, J.E.G., Fleer, A. and Snippe, H. Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides. Antonie van Leeuwenhoek 1990, 58, 1
27. Craig, S.W. and Cebra, J.J. Peyer's patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit. J. Exp. Med. 1971, 134, 188
28. Rudzik, O., Perey, D.Y.E. and Bienenstock, J. Differential IgA repopulation after transfer of autologous and allogeneic rabbit Peyer's patch cells. J. Immunol. 1975, 114, 40
29. Mosier, D.E. and Subbarao, B. Thymus-independent antigens: complexity of B lymphocyte activation revealed. Immunol. Today 1982, 3, 217
30. Garg, M., Kaplan, A.M. and Bondada, S. Cellular basis of differential responsiveness of lymph nodes and spleen to 23-valent Pnu-immune vaccine. J. Immunol. 1994, 152, 1589
31. Perlmutter, R.M., Hansburg, D., Briles, D.E., Nicolotti, R.A. and Davie, J.M. Subclass restriction of murine anticarbohydrate antibodies. J. immunol. 1978, 121, 566
32. Baker, P.J. Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes. Infect. Immun. 1990, 58, 3465
33. McGhee, J.R., Mestecky, J., Elson, C.O. and Kiyono, H. Regulation of IgA synthesis and immune response by T cells and interleukins. J. Clin. Immunol. 1989, 9, 75
34. Yin, J.-Z., Bell, M.K. and Thorbecke, G.J. Effect of various adjuvants on the antibody response of mice to pneumococcal polysaccharides. J. Biol. Res. Mod. 1989, 8, 190
35. Soesatyo, M., Van den Dobbelsteen, G.P.J.M., Van Rees, E.P., Biewenga, J. and Sminia, T. The in vivo antibody response in rat gut-associated lymphoid tissue (GALT) after immunization with bacterial polysaccharide antigen. Res. Immunol. 1993, 144, 121
36. van den Dobbelsteen, G.P.J.M., van Rooijen, N., Sminia, T. and van Rees, E.P. The immune response in the rat to Streptococcus pneumoniae type 3 and type 4 capsular polysaccharide: detection by double immunocytochemical staining of antibody-containing cells in situ and ELISA. J. Immunol. Meth. 1991, 145, 93
37. Sarvas, H., Rautonen, N., Sipinen, S. and Makela, O. IgG subclasses of Pneumococcal antibodies - effect of allotype G2m(n). Scand. J. Immunol. 1989, 29, 229
38. Heilmann, C.J. Henrichsen, J. and Pedersen, F.K. Vaccination-induced circulation of human B cells secreting type-specific antibodies against pneumococcal polysaccharides. Scand. J. Immunol. 1987, 25, 61
39. Lue, C., Tarkowski, A. and Mestecky, J. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. J. Immunol. 1988, 140, 3793
40. Tarkowski, A., Lue, C., Moldoveanu, Z., Kiyono, H., McGhee, J. and Mestecky, J. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses. J. Immunol. 1990, 144, 3770
41. Dertzbaugh, M.T. and Elson, C.O. Cholera toxin as a mucosal adjuvant. In: Topics in Vaccine Adjuvant Research (Eds Spriggs D.R. and Koff W.C.). CRC Press, Boca Raton, FL, 1991, pp. 119-131
42. Xu-Amano, J., Jackson, R.J., Fujihashi, K., Kiyono, H., Staats, H.F. and McGhee, J.R. Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine 1994, 12, 903
43. Xu-Amano, J., Kiyono, H., Jackson, R.J. et al. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 1993, 178, 1309
44. Munoz, E., Zubiaga, A.M., Merrow, M., Sauter, N.P. and Huber, B.T. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J. Exp. Med. 1990, 172, 95
45. Lycke, N. and Strober, W. Cholera toxin promotes B cell isotype differentiation. J. Immunol. 1989, 142, 3781
46. Lycke, N., Severinson, E. and Strober, W. Cholera toxin acts synergistically with IL-4 to promote IgG1 switch differentiation. J. Immunol. 1990, 145, 3316
47. Gregoriadis, G. Immunological adjuvants: a role for liposomes. Immunol. Today 1990, 11, 89
48. Husband, A.J. Novel vaccination strategies for the control of mucosal infection. Vaccine 1993, 112, 107
49. Allison, A.C. Adjuvants and immune enhancement. Int. J. Tech. Assess. Hlth Care 1994, 101, 107
50. Garcon, N.M.J. and Six, H.R. Universal vaccine carrier: liposomes that provide T dependent help to weak antigens. J. Immunol. 1991, 146, 3697